Erlotinib therapy in non small cell lung cancer patients - survival of patients on reduced erlotinib doses

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	PEŠEK Miloš KREJČÍ Jana SKŘIČKOVÁ Jana ZATLOUKAL Petr KOLEK Vítězslav SALAJKA František KOUBKOVÁ Leona SIXTOVÁ Dimka PETRUŽELKA Luboš ROUBEC Jaromír VYZULA Rostislav PAVLÍK Tomáš
Year of publication	2009
Type	Article in Periodical
Magazine / Source	Journal of Thoracic Oncology
MU Faculty or unit	Faculty of Medicine
Citation
Field	Pneumology
Keywords	erlotinib in reduced doses; treatment of NSCLC
Description	The question of survival of non small cell lung cancer patients treated with reduced doses of erlotinib is broached in the paper.
Related projects:	Environment - carcinogenesis - oncology